Dr. Xavier Intes has been named the J. Erik Jonsson ’22 Distinguished Professor at Rensselaer Polytechnic Institute. An endowed chaired professorship is among the highest honors bestowed on a Rensselaer faculty member.
Professor Intes is a Professor in the Department of Biomedical Engineering and co-director of CeMSIM. He is a nationally and internationally recognized expert in biomedical imaging with emphasis on biophotonics. Xavier has published approximately 126 peer-reviewed papers, many in high impact journals – Nature Photonics, PNAS, Science Advances, Light Science and Applications, Optica, Theranostics, Journal of Controlled Release, etc., 195 peer-reviewed transactions/proceedings, 10 invited book chapters, and edited two books. He has been awarded six patents and has been invited to present 76 professional lectures at universities and major conferences.
Dr. Intes has been recognized with several awards for his work. He is Fellow of the Optical Society of America (OSA), SPIE (the international society for optics and photonics), and the American Institute for Medical and Biological Engineering (AIMBE) which includes about 2% of the top biological scientists and engineers who have made significant contributions to the medical/biological engineering (MBE) community in academia, industry, government, and education. Xavier served as NIH Chartered Reviewer for the IGIS Study Section and the BMIT-B Study Section. He received NSF Career Award for ‘Whole-Body FRET Tomography’.
As a Program Director/Principal investigator, Prof. Intes has secured over $22Milllion of external funding with RPI as a prime institution, mainly from the NIH. As the co-director of the CeMSIM, Xavier has been instrumental in forging close collaborations with clinical partners. CeMSIM has secured over $120M in external funds over its history and has been central in supporting local collaborations, especially with Albany Medical College (AMC). Xavier has helped to establish CeMSIM’s culture, centered around grass root multidisciplinary and inclusive collaborations within RPI and the NY Capital Region community. CeMSIM has been a leader in surgical simulation, tissue modeling, and image-based biomechanics, as well as the development of novel approaches for neuromodulation and molecular imaging approaches to nondestructively assess both in vivo and in vitro models of disease (e.g., cancer).
Dr. Intes received four degrees, B.S., M.S., D.E.A., and Ph.D., from University of Bretagne Occidentale, Brest, France. Following this, he spent three years doing research in the Department of Biochemistry/Biophysics at the University of Pennsylvania and served as Director of Research at Medical Diagnostic Research Foundation and Chief Scientist of Biomedical Optical Imaging at Optical Devices, Inc. In 2003 he served as Director of Research at Biomedical Optical Imaging at Advanced Research Technology, Inc. in Canada before he joined the faculty at Rensselaer in 2006.
Learn more about Xavier Intes here: https://faculty.rpi.edu/xavier-intes